Antibodies & ADCs

Antibody drugs — including monoclonal antibodies (mAbs) and bispecific antibodies — and antibody-drug conjugates (ADCs) are the cornerstone of targeted therapy, delivering transformative outcomes in oncology and autoimmune diseases and forming the largest segment of the global biopharmaceutical market.

Throughout the full lifecycle of antibody and ADC drug manufacturing, filtration is the foundation for achieving high yield and high safety. Alioth offers comprehensive filtration solutions spanning fermentation broth clarification, culture media/buffer sterile filtration, bioburden reduction of intermediates, and fermentation gas filtration through to final drug product sterile filtration. Combined with professional process services and technical support, Alioth helps customers achieve high yield, high safety, and superior manufacturing economics for antibody and ADC drugs.